Orthopaedics 

Page 11 of 11
<< < ... 11 
  • Fashion conscious must weigh high-heeled hazards

    Does looking chic leave your feet screaming for help? Listen to them - not fashion pundits – for a change, says a foot and ankle expert. Dr. John Marymont, associate professor of orthopedic surgery at Baylor College of Medicine in Houston, said that wearing a two-inch heel subjects the ball of your foot to 50 percent more pressure than flat shoes.

    Baylor College of Medicine (Orthopaedics) - Tue, 16 January 2007
    http://www.bcm.edu

  • FDA Proposes Adding Vitamin D to Calcium Claim for Decreasing Osteoporosis Risk

    The US Food and Drug Administration (FDA) has proposed a new health claim for foods and dietary supplements containing calcium plus vitamin D that would allow manufacturers to advertise their potential to reduce the risk for osteoporosis.

    Medscape (Orthopaedics) - Tue, 16 January 2007
    http://www.medscape.com

  • SIMON, che cosa è e come nasce

    E' nato presso il reparto Ambiente e Traumi dell'Istituto Superiore di Sanità il sistema di sorveglianza epidemiologica SIMON (Sorveglianza degli Incidenti in MONtagna), che ha fornito già - grazie alla diffusione di due rapporti tecnici scaricabili dal sito dell'ISS- un quadro esaustivo sul fenomeno degli infortuni sulle pista da sci.

    Istituto Superiore di Sanità (Orthopaedics) - Thu, 4 January 2007
    http://www.iss.it/

  • Stretching for Plantar Fasciitis

    In a 2003 study some researchers had compared two different ways to treat plantar fasciitis: 82 patients who have been presenting this inflammation for at least 10 months had been treated with stretching exercise and the introduction of arch supports in shoes or with stretching of Achilles tendon.

    MedNews (Orthopaedics) - Fri, 22 December 2006
    http://mn.medsurfnews.com/

  • Bisphosphonate-Associated Osteonecrosis of the Jaw

    A 54-year-old man with a 3-year history of IgG myeloma, complicated by hypercalcemia, who was being treated with dexamethasone, lenalidomide, filgrastim, darbepoetin alfa, and pamidronate, presented with a 1-month history of severe bilateral jaw pain.

    New England Journal of Medicine (Orthopaedics) - Thu, 30 November 2006
    http://www.nejm.org

  • Osteonecrosis of the Jaw — Do Bisphosphonates Pose a Risk?

    Nitrogen-containing bisphosphonates are used widely for the management of metastatic cancer in bone (intravenous zoledronic acid or pamidronate), for the prevention and treatment of osteoporosis (oral alendronate, risedronate, and ibandronate and intravenous ibandronate), for the treatment of Paget's disease of bone (intravenous pamidronate and oral alendronate and risedronate), and for the short-term management of acute hypercalcemia (intravenous zoledronic acid and pamidronate).

    New England Journal of Medicine (Orthopaedics) - Thu, 30 November 2006
    http://www.nejm.org

  • Signaling for cartilage

    Skeletal progenitor cells differentiate into cartilage cells when one master gene actually suppresses the action of another, said Baylor College of Medicine researchers in a report that appears online in the journal Proceedings of the National Academy of Sciences.

    Baylor College of Medicine (Orthopaedics) - Wed, 29 November 2006
    http://www.bcm.edu

  • Inhaled Corticosteroid Use May Be an Independent Risk Factor for Fracture

    A study confirms that use of inhaled corticosteroids is associated with increased risk for fractures in patients with asthma or COPD.

    Medscape (Orthopaedics) - Tue, 17 October 2006
    http://www.medscape.com

  • Bone Density Evaluation in Teens Prevents Future Osteoporosis

    A review published in the October issue of the Archives of Pediatrics & Adolescent Medicine describes the most effective methods to evaluate bone density in teens to prevent future osteoporosis.

    Medscape (Orthopaedics) - Fri, 13 October 2006
    http://www.medscape.com

  • Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial

    Chronic symptomatic osteoarthritis of the hip is common in those aged over-50 and total hip replacement is a well established and highly effective treatment. Objectives of this study is to determine the benefits and risks of a non-steroidal anti-inflammatory drug (NSAID) as prophylaxis for ectopic bone formation in patients undergoing total hip replacement (or revision) surgery.

    British Medical Journal (Orthopaedics) - Wed, 12 July 2006
    http://www.bmjjournals.com

<< < ... 11 
Page 11 of 11